NEW YORK (360Dx) — Gregor Diagnostics announced today that it has raised $900,000 in seed funding, which the company will use to further develop its prostate cancer screening test.

The financing was led by First Round and Green Park & Golf Ventures. Other participants include the Wisconsin Alumni Research Foundation, Nat Turner and Zach Weinberg of Flatiron Health, existing investor Health Wildcatters.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.


In the last few years several molecular testing methodologies — such as immunohistochemistry, PCR, and sequencing — have been approved by the US Food and Drug Administration to aid in the management of patients with lung cancer.  


This webinar will provide a first-hand look at how the Dana-Farber Cancer Center is adapting its oncology care strategy in light of the rapidly evolving molecular landscape.

Sponsored by
Sophia Genetics

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.